The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
Nov. 25, 2014
Applicant:
Pharmabcine Inc., Daejeon, KR;
Inventors:
Jae Bong Yoon, Gangwon-do, KR;
Jinsang Yoo, Daejeon, KR;
Jin-San Yoo, Daejeon, KR;
Weon Sup Lee, Daejeon, KR;
Sung-Woo Kim, Daejeon, KR;
Sang Ryeol Shim, Daejeon, KR;
Sang Soon Byun, Daejeon, KR;
Youngae Lee, Daejeon, KR;
Hyuk Joon Lee, Daejeon, KR;
Do-yun Kim, Daejeon, KR;
Jinhee Choi, Daejeon, KR;
Assignee:
PHARMABCINE INC., Daejeon, KR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C12N 15/13 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 39/395 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 16/46 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/77 (2013.01);
Abstract
The present disclosure relates to an antibody specifically binding to epidermal growth factor receptor variant III (EGFRvIII), to nucleic acid coding the antibody, to a vector comprising the nucleic acid, to a host cell, to a preparation method of the antibody, and to a pharmaceutical composition comprising the antibody as an active ingredient for treating a cancer or a tumor.